These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1319956)

  • 1. Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation.
    Paya CV; Wiesner RH; Hermans PE; Larson-Keller JJ; Ilstrup DM; Krom RA; Moore SB; Ludwig J; Smith TF
    Hepatology; 1992 Jul; 16(1):66-70. PubMed ID: 1319956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation.
    O'Grady JG; Alexander GJ; Sutherland S; Donaldson PT; Harvey F; Portmann B; Calne RY; Williams R
    Lancet; 1988 Aug; 2(8606):302-5. PubMed ID: 2899720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
    Donaldson P; Underhill J; Doherty D; Hayllar K; Calne R; Tan KC; O'Grady J; Wight D; Portmann B; Williams R
    Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome.
    Arnold JC; Portmann BC; O'Grady JG; Naoumov NV; Alexander GJ; Williams R
    Hepatology; 1992 Aug; 16(2):285-92. PubMed ID: 1322347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic alpha-interferon expression in cytomegalovirus-infected liver allograft recipients with and without vanishing bile duct syndrome.
    Arnold JC; Nouri-Aria KT; O'Grady JG; Portmann BC; Alexander GJ; Williams R
    Clin Investig; 1993 Mar; 71(3):191-6. PubMed ID: 8386961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection as a possible risk factor for ductopenic rejection (vanishing bile duct syndrome) after liver transplantation.
    Hoffmann RM; Günther C; Diepolder HM; Zachoval R; Eissner HJ; Forst H; Anthuber M; Paumgartner G; Pape GR
    Transpl Int; 1995; 8(5):353-9. PubMed ID: 7576016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation.
    van den Berg AP; Klompmaker IJ; Hepkema BG; Gouw AS; Haagsma EB; Lems SP; The TH; Slooff MJ
    Transpl Int; 1996; 9 Suppl 1():S171-3. PubMed ID: 8959818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanishing bile-duct syndrome following liver transplantation--is it reversible?
    Hubscher SG; Buckels JA; Elias E; McMaster P; Neuberger J
    Transplantation; 1991 May; 51(5):1004-10. PubMed ID: 1851580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients.
    Ontañón J; Muro M; García-Alonso AM; Minguela A; Torío A; Bermejo J; Pons JA; Campos M; Alvarez-López MR
    Transplantation; 1998 Apr; 65(8):1047-53. PubMed ID: 9583864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation.
    Ludwig J; Wiesner RH; Batts KP; Perkins JD; Krom RA
    Hepatology; 1987; 7(3):476-83. PubMed ID: 3552923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanishing bile duct syndrome in a patient with advanced AIDS.
    Hindupur S; Yeung M; Shroff P; Fritz J; Kirmani N
    HIV Med; 2007 Jan; 8(1):70-2. PubMed ID: 17305935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts.
    Martelius T; Krogerus L; Höckerstedt K; Bruggeman C; Lautenschlager I
    Hepatology; 1998 Apr; 27(4):996-1002. PubMed ID: 9537439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent cytomegalovirus in liver allografts with chronic rejection.
    Lautenschlager I; Höckerstedt K; Jalanko H; Loginov R; Salmela K; Taskinen E; Ahonen J
    Hepatology; 1997 Jan; 25(1):190-4. PubMed ID: 8985289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex mismatch as a risk factor for chronic rejection of liver allografts.
    Candinas D; Gunson BK; Nightingale P; Hubscher S; McMaster P; Neuberger JM
    Lancet; 1995 Oct; 346(8983):1117-21. PubMed ID: 7475600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of cytomegalovirus infection and HLA antigen matching on the outcome of renal transplantation.
    May AG; Betts RF; Freeman RB; Andrus CH
    Ann Surg; 1978 Feb; 187(2):110-7. PubMed ID: 204263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin's lymphoma-related vanishing bile duct syndrome: a case report and literature review.
    Wong KM; Chang CS; Wu CC; Yin HL
    Kaohsiung J Med Sci; 2013 Nov; 29(11):636-41. PubMed ID: 24183359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
    Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
    World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation.
    Mañez R; White LT; Linden P; Kusne S; Martin M; Kramer D; Demetris AJ; Van Thiel DH; Starzl TE; Duquesnoy RJ
    Transplantation; 1993 May; 55(5):1067-71. PubMed ID: 8388584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
    Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed granuloma formation in a patient with vanishing bile duct syndrome 7 years post-liver transplantation.
    Anania FA; Howell CD; Laurin JM; Drachenberg CI
    Liver Transpl; 2001 Nov; 7(11):999-1001. PubMed ID: 11699038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.